期刊
ACTA HAEMATOLOGICA
卷 127, 期 4, 页码 235-243出版社
KARGER
DOI: 10.1159/000336241
关键词
Alemtuzumab; Kaposi sarcoma; Pentostatin; Prolymphocytes; T cell prolymphocytic leukemia
类别
T cell prolymphocytic leukemia (T-PLL) is a rare mature T cell lymphoproliferative disease. It has been associated with an aggressive course, a poor response to conventional chemotherapy and a short median survival. Here we present a rare case of concurrent T-PLL and Kaposi sarcoma who achieved a complete hematologic and cytogenetic remission after a very short course of treatment with alemtuzumab. A review of T-PLL was done. In this review, clinical features, laboratory features and current therapeutic strategies of T-PLL are presented. Copyright (C) 2012 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据